Guidance
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Published guidance on this topic (10)
- New guidance in the last 6 months (2)
- Updated guidance in the last 6 months (0)
- In development guidance (1)
NICE advice
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Published advice on this topic (1)
- New advice in the last 6 months (0)
- Updated advice in the last 6 months (0)
- In development advice (0)
Quality standards
Set out priority areas for quality improvement in health and social care.
Published quality standards on this topic (1)
- New quality standards in the last 6 months (0)
- Updated quality standards in the last 6 months (0)
- In development quality standards (0)
NICE Pathways
Interactive topic-based flowcharts that allow you to navigate our recommendations on any subject.
Guidance by programme
-
NICE guidelines (1)
Review the evidence across broad health and social care topics.
-
Technology appraisal guidance (4)
Review clinical and cost effectiveness of new treatments.
-
Interventional procedures guidance (7)
Assessments of whether procedures are safe enough and work well enough for wider use in the NHS.
Advice by programme
-
Evidence summaries (1)
Review the best available evidence for selected medicines.
Products being developed or updated
-
In development (1)
Guidance, quality standards and advice being developed.
-
Proposed (1)
Technology appraisal guidance which has been proposed for development.
15 Products
In development (1) | Proposed (1)
There are 1
new
and 0
updated
products since
April 2018
NICE Pathways
Interactive topic-based flowcharts that allow you to navigate our recommendations on any subject. Find out more about NICE Pathways.
NICE guidelines
Review the evidence across broad health and social care topics.
Quality standards
Set out priority areas for quality improvement in health and social care.
Technology appraisal guidance
Review clinical and cost effectiveness of new treatments.
-
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine (TA260)
-
Tocilizumab for treating giant cell arteritis (TA518)
Interventional procedures guidance
Assessments of whether procedures are safe enough and work well enough for wider use in the NHS.
-
Deep brain stimulation for intractable trigeminal autonomic cephalalgias (IPG381)
-
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache (IPG527)
-
Occipital nerve stimulation for intractable chronic migraine (IPG452)
-
Percutaneous closure of patent foramen ovale for recurrent migraine (IPG370)
-
Transcranial magnetic stimulation for treating and preventing migraine (IPG477)
-
Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine (IPG559)
-
Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine (IPG552)
Evidence summaries
Review the best available evidence for selected medicines.
In development
Proposed
New guidance and advice
Guidance and advice added since April 2018
Putting guidance into practice
Shared learning
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 1 of 1 shared learning examples for this topic: